Cannabis Group Weekly Alert – July 2019
This week: A Senate hearing on cannabis banking legislation; FDA sends Curaleaf a letter alleging that certain CBD products are unapproved and misbranded drugs in violation of the FD&C; While states continue to embrace industrial hemp. Federal The Senate Committee on Banking, Housing, and Urban Affairs conducted a hearing entitled, “Challenges for Cannabis and Banking: Outside …